Characterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirus
出版年份 2020 全文链接
标题
Characterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirus
作者
关键词
Coronaviruses, Antibodies, B cells, Polymerase chain reaction, Prophylaxis, Respiratory infections, Enzyme-linked immunoassays, Mouse models
出版物
PLoS One
Volume 15, Issue 5, Pages e0232757
出版商
Public Library of Science (PLoS)
发表日期
2020-05-09
DOI
10.1371/journal.pone.0232757
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection
- (2019) Anna Z. Wec et al. Cell Host & Microbe
- Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient
- (2018) Peihua Niu et al. JOURNAL OF INFECTIOUS DISEASES
- A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV
- (2018) Guangyu Zhao et al. JOURNAL OF VIROLOGY
- Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study
- (2018) John H Beigel et al. LANCET INFECTIOUS DISEASES
- Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea
- (2018) Myoung-don Oh et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Ibalizumab in Multidrug-Resistant HIV — Accepting Uncertainty
- (2018) Virginia Sheikh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chimeric camel/human heavy-chain antibodies protect against MERS-CoV infection
- (2018) V. Stalin Raj et al. Science Advances
- Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem
- (2018) Hyon-Xhi Tan et al. JOURNAL OF CLINICAL INVESTIGATION
- Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset
- (2017) Zhe Chen et al. JOURNAL OF INFECTIOUS DISEASES
- Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity
- (2017) Gwo-Yu Chuang et al. JOURNAL OF VIROLOGY
- Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
- (2017) Jesper Pallesen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein
- (2017) Wentao Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Performance Evaluation of the PowerChek MERS (upE & ORF1a) Real-Time PCR Kit for the Detection of Middle East Respiratory Syndrome Coronavirus RNA
- (2017) Hee Jae Huh et al. Annals of Laboratory Medicine
- Antibody therapies for the prevention and treatment of viral infections
- (2017) Georgina Salazar et al. npj Vaccines
- Generation of a Transgenic Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease
- (2015) Anurodh Shankar Agrawal et al. JOURNAL OF VIROLOGY
- I-TASSER server: new development for protein structure and function predictions
- (2015) Jianyi Yang et al. NUCLEIC ACIDS RESEARCH
- Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus
- (2015) Davide Corti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection
- (2015) Kristen E. Pascal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluation of candidate vaccine approaches for MERS-CoV
- (2015) Lingshu Wang et al. Nature Communications
- Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27
- (2015) Xiaojuan Yu et al. Scientific Reports
- Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study
- (2014) Jaffar A. Al-Tawfiq et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies
- (2014) Tianlei Ying et al. JOURNAL OF VIROLOGY
- Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution
- (2014) X.-C. Tang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein
- (2014) L. Jiang et al. Science Translational Medicine
- Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
- (2013) Nianshuang Wang et al. CELL RESEARCH
- Serverification of Molecular Modeling Applications: The Rosetta Online Server That Includes Everyone (ROSIE)
- (2013) Sergey Lyskov et al. PLoS One
- Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
- (2013) J. S. McLellan et al. SCIENCE
- Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
- (2010) X. Wu et al. SCIENCE
- SnugDock: Paratope Structural Optimization during Antibody-Antigen Docking Compensates for Errors in Antibody Homology Models
- (2010) Aroop Sircar et al. PLoS Computational Biology
- Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen
- (2009) Kenneth Smith et al. Nature Protocols
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started